Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus bupivacaine hydrochloride for posterior laminar block after posterior lumbar surgery
ChiCTR2400091488Phase 4Recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Oct 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine and bupivacaine in postoperative pain (2 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoints: Blood concentration of bupivacaine, Visual analogue scale pain score and 2 more. Started Oct 2024; status: recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400091488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091488.